| David W Devine, CRNA | |
|
995 9th Ave Sw, Bessemer, AL 35022-4527 | |
| (205) 481-7000 | |
| Not Available |
| Full Name | David W Devine |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 995 9th Ave Sw, Bessemer, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164574687 | NPI | - | NPPES |
| 5884851 | Other | AL | DRIVERS LIC NEW PROVIDER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1-093384 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northport - Crna | 3971791286 | 18 |
| Vision Correction Center, Llc | 9537051024 | 5 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).
DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.
A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.
› Verified 3 days ago
| Entity Name | Vision Correction Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497817605 PECOS PAC ID: 9537051024 Enrollment ID: O20050124000332 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).
DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.
A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.
› Verified 3 days ago
| Entity Name | Northport - Crna |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265734271 PECOS PAC ID: 3971791286 Enrollment ID: O20101230000056 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).
DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.
A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.
› Verified 3 days ago
| Entity Name | Dch Medical Center Crna |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356642045 PECOS PAC ID: 5395933626 Enrollment ID: O20101230000396 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).
DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.
A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.
› Verified 3 days ago
| Entity Name | Capstone Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073934675 PECOS PAC ID: 0648401679 Enrollment ID: O20140314001809 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).
DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.
A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.
› Verified 3 days ago
| Entity Name | Medfusions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093275364 PECOS PAC ID: 7315270253 Enrollment ID: O20190610000970 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).
DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.
A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David W Devine, CRNA 3620 White Oaks Rdg, Tuscaloosa, AL 35406-4413 Ph: (205) 657-8725 | David W Devine, CRNA 995 9th Ave Sw, Bessemer, AL 35022-4527 Ph: (205) 481-7000 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
Kenneth Merten, the U.S. ambassador to Haiti, said on Thursday that American troops would stay in the country to aid in its recovery, Agence France-Presse reports. "There are about 6,500 soldiers in Haiti at the moment. There were some 20,000 for the emergency effort launched in the wake of January 12," Merten said. "What is planned for the moment is more and more staff from USAID on the ground and fewer and fewer troops. Gradually, they'll leave. In my opinion, we will need some American troops to stay here for the foreseeable future" (2/25).
DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.
A core tenet of precision medicine is that predictive biomarkers can enhance therapeutic decision-making. In a new pilot study, scientists at Molecular Health analyzed a randomly selected set of 250 patients with solid tumors and detected predictive biomarkers in more than 85% of tumors.
› Verified 3 days ago
Keith Joseph Brown, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 995 9th Ave Sw, Bessemer, AL 35022 Phone: 205-481-7670 | |
Johnny V Moore, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 995 9th Ave Sw, Bessemer, AL 35022 Phone: 205-481-7670 | |
Larry Wayne Ruff, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 995 9th Ave Sw, Bessemer, AL 35022 Phone: 205-481-7670 | |
James Warren Ballard, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 995 9th Ave Sw, Bessemer, AL 35022 Phone: 205-481-7670 | |
Ms. Patsy Ann Langford, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 995 9th Ave Sw, Bessemer, AL 35022 Phone: 205-481-8729 Fax: 205-481-8732 | |
John Kevin Ewing, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 995 9th Ave Sw, Bessemer, AL 35022 Phone: 205-481-7670 |